Akamai Technologies (NASDAQ:AKAM) signs a $11.6 billion cloud agreement with Anthropic, boosting shares and increasing ...

Addex Therapeutics (NASDAQ:ADXN) regains global rights to GABAB PAM assets from Indivior and evaluates future development ...

REGENXBIO reported three-year ALTITUDE trial data for investigational sura-vec in non-proliferative diabetic retinopathy.

Anthropic PBC has signed an $11.6 billion, seven-year contract with Akamai Technologies Inc. for computing power, building on ...

US and Iranian negotiators are exploring a phased deal that would see Tehran reopen the Strait of Hormuz and Washington lift ...

Torsten Slok, chief economist at Apollo, warns that inflation from rising diesel prices may not be taken into account by the ...

Planet Labs (NYSE:PL) prepares Pelican-12 for SpaceX Bandwagon-5 launch with upgraded imaging, communications, and AI ...

Legend Biotech (NASDAQ:LEGN) reports five-year CARVYKTI data showing 69.2% overall survival and 60.5-month progression-free ...

Ocugen (NASDAQ:OCGN) receives provisional approval for OCU400 in The Bahamas as Phase 3 gene therapy testing continues.

Nektar Therapeutics (NASDAQ:NKTR) receives a $90 million jury award in a license agreement dispute with Eli Lilly over ...

AstraZeneca (NASDAQ:AZN) receives FDA Priority Review for IMFINZI plus enfortumab vedotin in muscle-invasive bladder cancer ...

XCF Global (NASDAQ:SAFX) reports more than $10 million in August revenue after shipping 1.3 million gallons of renewable ...